Skip to content
10-Q

Quarterly Report

GoodRx Holdings, Inc. GDRX

0001809519-26-000111

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2026 · Mar 31, 2026 341.42M sh
Shares Diluted Q1 2026 · Mar 31, 2025 379.66M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $12.57M
Stock Repurchased Q1 2026 · Mar 31, 2025 $99.9M
Capex Q1 2026 · Mar 31, 2026 $1.14M
Capex Q1 2026 · Mar 31, 2025 $142K
Operating Cash Flow Q1 2026 · Mar 31, 2026 $11.84M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $9.41M
Long Term Debt Q1 2026 · Mar 31, 2026 $482.42M
Long Term Debt Q1 2026 · Dec 31, 2025 $483.26M
Short Term Debt Q1 2026 · Mar 31, 2026 $5M
Short Term Debt Q1 2026 · Dec 31, 2025 $5M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $235.71M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $261.82M
Stockholders Equity Q1 2026 · Mar 31, 2026 $621.99M
Stockholders Equity Q1 2026 · Dec 31, 2025 $616.26M
Stockholders Equity Q1 2026 · Mar 31, 2025 $654.35M
Stockholders Equity Q1 2026 · Dec 31, 2024 $724.66M
Current Liabilities Q1 2026 · Mar 31, 2026 $859.2M
Current Liabilities Q1 2026 · Dec 31, 2025 $246M
Total Liabilities Q1 2026 · Mar 31, 2026 $1.4B
Total Liabilities Q1 2026 · Dec 31, 2025 $787.8M
Current Assets Q1 2026 · Mar 31, 2026 $1.27B
Current Assets Q1 2026 · Dec 31, 2025 $643.1M
Total Assets Q1 2026 · Mar 31, 2026 $2.02B
Total Assets Q1 2026 · Dec 31, 2025 $1.4B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.00
Eps Diluted Q1 2026 · Mar 31, 2025 $0.03
Eps Basic Q1 2026 · Mar 31, 2026 $0.00
Eps Basic Q1 2026 · Mar 31, 2025 $0.03
Sga Expense Q1 2026 · Mar 31, 2026 $26.82M
Sga Expense Q1 2026 · Mar 31, 2025 $29.63M
Rd Expense Q1 2026 · Mar 31, 2026 $30.18M
Rd Expense Q1 2026 · Mar 31, 2025 $31.14M
Net Income Q1 2026 · Mar 31, 2026 $1.17M
Net Income Q1 2026 · Mar 31, 2025 $11.05M
Operating Income Q1 2026 · Mar 31, 2026 $14.01M
Operating Income Q1 2026 · Mar 31, 2025 $23.38M
Revenue Q1 2026 · Mar 31, 2026 $194.01M
Revenue Q1 2026 · Mar 31, 2025 $202.97M